What are the common and serious side effects of local anesthetic agents?

Side Effects of Local Anesthesia

Local anesthetics can cause both common minor effects and rare but life-threatening systemic toxicity, with the most serious complications being central nervous system toxicity (seizures, loss of consciousness) and cardiovascular collapse (bradycardia, cardiac arrest), occurring in approximately 1-11 cases per 10,000 administrations. 1

Central Nervous System (CNS) Toxicity

Early warning signs that require immediate recognition include: 2, 1

• Slurred speech
• Circumoral numbness and facial tingling
• Metallic taste in the mouth
• Tinnitus (ringing in ears)
• Light-headedness

Progressive CNS toxicity manifests as: 1, 3

• Excitation and agitation
• Seizures/convulsions
• Loss of consciousness
• Respiratory arrest

These symptoms occur when protein-unbound plasma concentrations exceed safe levels, with toxic levels beginning at approximately 6 μg/mL and serious toxicity at 9-10 μg/mL. 2

Cardiovascular Toxicity

Early cardiovascular signs include: 1

• Hypertension
• Tachycardia
• Premature ventricular contractions

Severe cardiovascular complications develop with further increases in plasma concentration: 1, 4

• Bradycardia
• Conduction disturbances
• Severe hypotension
• Circulatory collapse
• Cardiac arrest
• Asystole

In the French pharmacovigilance database analysis, 22 of 111 cardiovascular complications were cardiac arrests, with three proving fatal. 4

Allergic and Hypersensitivity Reactions

True allergic reactions are rare, representing only 1% of all adverse reactions to local anesthetics. 5, 6

Allergic manifestations range from: 7, 4

• Mild skin reactions (rash, urticaria)
• Anaphylactoid reactions
• Life-threatening anaphylaxis

Ester-type local anesthetics cause allergic reactions more frequently than amide-type agents, often due to paraben preservatives in amide preparations rather than the anesthetic itself. 5, 6

Procedure-Related Complications

Technical failures and local complications include: 4

• Failure of the block (27.7% of reported adverse events in French database)
• Wound cellulitis
• Seroma formation
• Urinary retention

Notably, spinal anesthesia performed with bupivacaine represented 90% of failed blocks in one large analysis. 4

High-Risk Patient Populations

Patients at increased risk for systemic toxicity include: 2, 1

• Infants (especially those younger than 6 months)
• Patients with hepatic dysfunction
• Those with cardiac failure or low cardiac output
• Patients with hypoalbuminemia
• Those with low body weight or reduced muscle mass
• Patients with acidemia
• Those taking beta-blockers or amiodarone

Critical Prevention Strategies

To minimize the risk of local anesthetic systemic toxicity (LAST), the American Academy of Dermatology and other societies recommend: 5, 2

• Use the lowest effective dose and concentration
• Always aspirate before each injection to avoid intravascular administration
• Inject slowly with frequent aspiration, especially in highly vascular tissues
• Use incremental injections rather than bolus dosing
• Monitor vital signs every 5 minutes when using high doses
• Adhere to maximum safe doses: adults 7 mg/kg lidocaine with epinephrine (up to 500 mg) or 4.5 mg/kg without epinephrine; children 3.0-4.5 mg/kg with epinephrine or 1.5-2.0 mg/kg without epinephrine
• Calculate doses using ideal body weight in patients with BMI > 30 kg/m² to avoid inadvertent overdosing
• Wait at least 4 hours between lidocaine infiltration and any other local anesthetic intervention to prevent cumulative toxicity
• Have 20% lipid emulsion immediately available for rescue therapy

Emerging Safety Concerns

Recent evidence reveals extensive crystallization in certain local anesthetic mixtures, including previously considered "safe" combinations like lidocaine plus sodium bicarbonate, raising concerns about particle formation and unclear safety profiles. 8 Despite guideline recommendations for some mixtures, the unclear safety profile and equivocal clinical benefit warrant caution, especially for neuraxial techniques. 8

Common Pitfalls to Avoid

Frequent errors that increase toxicity risk include: 2

• Using actual body weight instead of ideal body weight in obese patients
• Failing to account for cumulative doses from multiple injection sites
• Not reducing doses for prolonged infusions beyond 12-24 hours
• Ignoring drug interactions with beta-blockers, amiodarone, and CYP450 inhibitors
• Applying excessive topical doses to mucosal surfaces where systemic uptake is rapid
• Injecting too rapidly, which increases both pain and systemic absorption
• Forgetting to aspirate before injection